Literature DB >> 26208400

Interacting partners of macrophage-secreted cathepsin B contribute to HIV-induced neuronal apoptosis.

Yisel M Cantres-Rosario1, Natalia Hernandez, Karla Negron, Juliana Perez-Laspiur, John Leszyk, Scott A Shaffer, Loyda M Meléndez.   

Abstract

OBJECTIVE: HIV-1 infection of macrophages increases cathepsin B secretion and induces neuronal apoptosis, but the molecular mechanism remains unclear.
DESIGN: We identified macrophage-secreted cathepsin B protein interactions extracellularly and their contribution to neuronal death in vitro.
METHODS: Cathepsin B was immunoprecipitated from monocyte-derived macrophage supernatants after 12 days postinfection. The cathepsin B interactome was identified by label-free tandem mass spectrometry and compared with uninfected supernatants. Proteins identified were validated by western blot. Neurons were exposed to macrophage-conditioned media in presence or absence of antibodies against cathepsin B and interacting proteins. Apoptosis was measured using TUNEL labeling. Immunohistochemistry of postmortem brain tissue samples from healthy, HIV-infected and Alzheimer's disease patients was performed to observe the ex-vivo expression of the proteins identified.
RESULTS: Nine proteins co-immunoprecipitated differentially with cathepsin B between uninfected and HIV-infected macrophages. Serum amyloid P component (SAPC)-cathepsin B interaction increased in HIV-infected macrophage supernatants, while matrix metalloprotease 9 (MMP-9)-cathepsin B interaction decreased. Pre-treatment of HIV-infected macrophage-conditioned media with antibodies against cathepsin B and SAPC decreased neuronal apoptosis. The addition of MMP-9 antibodies was not neuro-protective SAPC was overexpressed in postmortem brain tissue from HIV-positive neurocognitive impaired patients compared with HIV positive with normal cognition and healthy controls, although MMP-9 expression was similar in all tissues.
CONCLUSION: Inhibiting SAPC-cathepsin B interaction protects against HIV-induced neuronal death and may help to find alternative treatments for HIV-associated neurocognitive disorders.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26208400      PMCID: PMC4636939          DOI: 10.1097/QAD.0000000000000823

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  55 in total

1.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

2.  The cysteine protease inhibitor, E64d, reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, β-secretase activity.

Authors:  Gregory Hook; Vivian Hook; Mark Kindy
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

3.  Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism.

Authors:  Ke-Jie Yin; John R Cirrito; Ping Yan; Xiaoyan Hu; Qingli Xiao; Xiaoou Pan; Randall Bateman; Haowei Song; Fong-Fu Hsu; John Turk; Jan Xu; Chung Y Hsu; Jason C Mills; David M Holtzman; Jin-Moo Lee
Journal:  J Neurosci       Date:  2006-10-25       Impact factor: 6.167

4.  Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate beta-secretase of Alzheimer's disease.

Authors:  Vivian Hook; Thomas Toneff; Matthew Bogyo; Doron Greenbaum; Katalin F Medzihradszky; John Neveu; William Lane; Gregory Hook; Terry Reisine
Journal:  Biol Chem       Date:  2005-09       Impact factor: 3.915

5.  FcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer's disease.

Authors:  Tae-In Kam; Sungmin Song; Youngdae Gwon; Hyejin Park; Ji-Jing Yan; Isak Im; Ji-Woo Choi; Tae-Yong Choi; Jeongyeon Kim; Dong-Keun Song; Toshiyuki Takai; Yong-Chul Kim; Key-Sun Kim; Se-Young Choi; Sukwoo Choi; William L Klein; Junying Yuan; Yong-Keun Jung
Journal:  J Clin Invest       Date:  2013-06-10       Impact factor: 14.808

6.  Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40).

Authors:  J R Backstrom; G P Lim; M J Cullen; Z A Tökés
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

7.  Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.

Authors:  M B Pepys; J Herbert; W L Hutchinson; G A Tennent; H J Lachmann; J R Gallimore; L B Lovat; T Bartfai; A Alanine; C Hertel; T Hoffmann; R Jakob-Roetne; R D Norcross; J A Kemp; K Yamamura; M Suzuki; G W Taylor; S Murray; D Thompson; A Purvis; S Kolstoe; S P Wood; P N Hawkins
Journal:  Nature       Date:  2002-05-16       Impact factor: 49.962

Review 8.  Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis.

Authors:  Dionna W Williams; Eliseo A Eugenin; Tina M Calderon; Joan W Berman
Journal:  J Leukoc Biol       Date:  2012-01-06       Impact factor: 4.962

9.  HIV-1 activates proinflammatory and interferon-inducible genes in human brain microvascular endothelial cells: putative mechanisms of blood-brain barrier dysfunction.

Authors:  Anathbandhu Chaudhuri; Fenghai Duan; Brenda Morsey; Yuri Persidsky; Georgette D Kanmogne
Journal:  J Cereb Blood Flow Metab       Date:  2007-10-17       Impact factor: 6.200

10.  Genetic cathepsin B deficiency reduces beta-amyloid in transgenic mice expressing human wild-type amyloid precursor protein.

Authors:  Vivian Y H Hook; Mark Kindy; Thomas Reinheckel; Christoph Peters; Gregory Hook
Journal:  Biochem Biophys Res Commun       Date:  2009-06-06       Impact factor: 3.575

View more
  8 in total

1.  Dimethyl Fumarate Prevents HIV-Induced Lysosomal Dysfunction and Cathepsin B Release from Macrophages.

Authors:  Lester J Rosario-Rodríguez; Krystal Colón; Gabriel Borges-Vélez; Karla Negrón; Loyda M Meléndez
Journal:  J Neuroimmune Pharmacol       Date:  2018-07-09       Impact factor: 4.147

Review 2.  Extracellular Vesicles and HIV-Associated Neurocognitive Disorders: Implications in Neuropathogenesis and Disease Diagnosis.

Authors:  Lee A Campbell; Italo Mocchetti
Journal:  Neurotox Res       Date:  2021-10-07       Impact factor: 3.911

3.  Inhibition of Cathepsin B and SAPC Secreted by HIV-Infected Macrophages Reverses Common and Unique Apoptosis Pathways.

Authors:  Camille N Zenón-Meléndez; Kelvin Carrasquillo Carrión; Yadira Cantres Rosario; Abiel Roche Lima; Loyda M Meléndez
Journal:  J Proteome Res       Date:  2022-01-07       Impact factor: 5.370

4.  Microwave & magnetic proteomics of macrophages from patients with HIV-associated cognitive impairment.

Authors:  Yisel M Cantres-Rosario; Frances M Acevedo-Mariani; Juliana Pérez-Laspiur; William E Haskins; Marines Plaud; Yadira M Cantres-Rosario; Richard Skolasky; Israel Méndez-Bermúdez; Valerie Wojna; Loyda M Meléndez
Journal:  PLoS One       Date:  2017-07-26       Impact factor: 3.240

5.  HIV Infection Induces Extracellular Cathepsin B Uptake and Damage to Neurons.

Authors:  Yisel M Cantres-Rosario; Sarah C Ortiz-Rodríguez; Aemil G Santos-Figueroa; Marines Plaud; Karla Negron; Bianca Cotto; Dianne Langford; Loyda M Melendez
Journal:  Sci Rep       Date:  2019-05-29       Impact factor: 4.379

6.  Cannabinoid receptor type 2 agonist JWH-133 decreases cathepsin B secretion and neurotoxicity from HIV-infected macrophages.

Authors:  Lester J Rosario-Rodríguez; Yamil Gerena; Luis A García-Requena; Luz J Cartagena-Isern; Juan C Cuadrado-Ruiz; Gabriel Borges-Vélez; Loyda M Meléndez
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

Review 7.  Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders.

Authors:  Amila Omeragic; Olanre Kayode; Md Tozammel Hoque; Reina Bendayan
Journal:  Fluids Barriers CNS       Date:  2020-07-10

8.  Sigma-1 Receptor Antagonist (BD1047) Decreases Cathepsin B Secretion in HIV-Infected Macrophages Exposed to Cocaine.

Authors:  Omar Vélez López; Santhi Gorantla; Annabell C Segarra; María C Andino Norat; Manuel Álvarez; Richard L Skolasky; Loyda M Meléndez
Journal:  J Neuroimmune Pharmacol       Date:  2018-10-10       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.